Researcher.Life Logo

Cancers : Impact Factor & More

eISSN: 2072-6694pISSN: 2072-6694
JournalOpen Access

Key Metrics

CiteScore
5.8
Impact Factor
5 - 10
Scite Index
0.90 5-Year SI
SNIP
1.27
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Cancers

Cancers Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher MDPI
Language English
Frequency Semi-monthly
Article Processing ChargesCHF 2600
Publication Time6
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencySemi-monthly
Publication Start Year2009
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 6
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY
OA statementVisit website
View less

Planning to publish in Cancers ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Cancers

Predicting Toxicities and Survival Outcomes in De Novo Metastatic Hormone-Sensitive Prostate Cancer Using Clinical Features, Routine Blood Tests and Their Early Variations
  • 27 Nov 2025
  • Cancers
Tissue Microarray-Based Digital Spatial Profiling of Benign Breast Lobules and Breast Cancers: Feasibility, Biological Coherence, and Cross-Platform Benchmarks
  • 27 Nov 2025
  • Cancers
Serum Glucose-6-Phosphate Dehydrogenase Activity as a Biomarker for Gastric Cancer Stage Prediction
  • 27 Nov 2025
  • Cancers
Impact of Postoperative Radiotherapy on the Risk of Ischemic Heart Disease and Survival in Patients with Ductal Carcinoma In Situ: A Nationwide Claims-Based Cohort Study
  • 27 Nov 2025
  • Cancers
CIN2 and Active Surveillance: Evidence from 48-Month Follow-Up in an HPV-Positive Cohort
  • 27 Nov 2025
  • Cancers
Non-Contrast MR T2-Weighted Imaging Is as Accurate as Contrast-Enhanced T1-Weighted Imaging in the Detection of Meningioma Growth
  • 27 Nov 2025
  • Cancers
Predicting Toxicities and Survival Outcomes in De Novo Metastatic Hormone-Sensitive Prostate Cancer Using Clinical Features, Routine Blood Tests and Their Early Variations
  • 27 Nov 2025
  • Cancers
Tissue Microarray-Based Digital Spatial Profiling of Benign Breast Lobules and Breast Cancers: Feasibility, Biological Coherence, and Cross-Platform Benchmarks
  • 27 Nov 2025
  • Cancers
Serum Glucose-6-Phosphate Dehydrogenase Activity as a Biomarker for Gastric Cancer Stage Prediction
  • 27 Nov 2025
  • Cancers
Impact of Postoperative Radiotherapy on the Risk of Ischemic Heart Disease and Survival in Patients with Ductal Carcinoma In Situ: A Nationwide Claims-Based Cohort Study
  • 27 Nov 2025
  • Cancers
CIN2 and Active Surveillance: Evidence from 48-Month Follow-Up in an HPV-Positive Cohort
  • 27 Nov 2025
  • Cancers
Non-Contrast MR T2-Weighted Imaging Is as Accurate as Contrast-Enhanced T1-Weighted Imaging in the Detection of Meningioma Growth
  • 27 Nov 2025
  • Cancers

FAQs on Cancers